Akcea Therapeutics, Inc. (AKCA)
Q3 2019 Earnings Conference Call
November 5, 2019 4:30 p.m. ET
Company Participants
Kathleen Gallagher - VP of Corporate Communications and IR
Damien McDevitt - Interim CEO
Mike MacLean - CFO
Kyle Jenne - Chief Commercial Officer
Conference Call Participants
Gil Blum - Needham & Company
Jamison Phillips-Crone - BMO Capital Markets
Jim Birchenough - Wells Fargo
Nate Tower - Stifel Nicolaus
Ritu Baral - Cowen & Company
Presentation
Operator
Good afternoon, and welcome to the Akcea Therapeutics Third Quarter 2019 Conference Call. As a reminder, this call is being recorded.